Visceral Adipose Tissue (VAT) as a Major Modifiable Driver of Cardiometabolic Risk

Dr Edward Leatham
Jun 24
5 min read

An article written by Dr Edward Leatham, Consultant Cardiologist

Why the fat you cannot see is the fat that matters most — and what you can do to measure, understand and reduce it

For busy people, or to tune in when on the move, a Google NotebookLM audio podcast is available as a story beneath.

Two people can walk into a clinic with identical weights, identical BMIs, and a vastly different risk of heart attack, type 2 diabetes and stroke — and the hidden difference is almost always visceral fat. For decades, cardiovascular prevention has focused on blood pressure, cholesterol and blood sugar, but a growing and compelling body of evidence suggests we have been overlooking one of the most powerful drivers of disease sitting right in front of us — literally. In this article you will learn what visceral fat actually does inside your body, why your bathroom scales cannot tell you whether you have it, and what practical steps you can take today to start reducing it.

The Patient Nobody Expected to Be at Risk

Picture two men, both fifty-two years old, both weighing fourteen stone, both with a BMI sitting neatly in the "overweight" category. On paper, they look almost identical. But when you scan inside their abdomens, you find something striking. The first man carries most of his fat just beneath the skin — a soft layer that wobbles when he moves, but sits there largely minding its own business. The second man, despite looking similar from the outside, is carrying a dense pack of fat wrapped around his liver, his kidneys, and the root of his intestines. Same weight. Completely different biology.

This is the visceral fat problem in a single image, and it explains why BMI — body mass index, the calculation based on your height and weight — has such a frustrating track record when it comes to predicting who actually ends up having a heart attack.

The INTERHEART study, which followed over twenty-seven thousand participants across fifty-two countries, found that waist-to-hip ratio outperformed BMI as a predictor of myocardial infarction — a heart attack — across every region studied. UK Biobank data, using CT and MRI imaging to directly measure fat compartments, has since confirmed that visceral fat volume predicts cardiovascular events independently of total body weight. In other words, where the fat lives matters more than how much fat you carry in total.

This is not a minor statistical footnote. It means that a lean person with a modest amount of visceral fat can carry significantly more cardiometabolic risk than a heavier person whose fat is stored subcutaneously, beneath the skin. It means that waist circumference — and more accurately, waist-to-height ratio — tells a doctor something that a set of scales simply cannot.

If you are in the UK, a waist measurement above 94 cm for men or 80 cm for women is considered elevated risk. In the USA, the thresholds used clinically are typically 102 cm for men and 88 cm for women, though many researchers now argue these figures are too generous. A simpler rule, supported by a substantial body of research, is that your waist should be less than half your height. That single calculation — waist divided by height — predicts cardiometabolic risk with remarkable accuracy across different ethnicities and body types.

What Visceral Fat Is Actually Doing Inside You

Here is the critical thing that separates visceral fat from the fat under your skin. Visceral fat is not inert storage — it is a fully active endocrine organ. It produces and secretes hormones, inflammatory signals and other chemical messengers, and because of its location deep inside the abdomen, it drains directly into the portal vein — the major blood vessel that feeds the liver.

Think of it this way. Subcutaneous fat is like a warehouse on the edge of town. It holds supplies, it can grow larger than ideal, but it is not connected directly to the factory floor. Visceral fat, by contrast, is a factory installed inside the building — one that continuously pumps its output straight into the heart of operations.

That output includes TNF-alpha and interleukin-6, which are potent inflammatory signals; free fatty acids, which flood the liver and drive fat accumulation there; and plasminogen activator inhibitor-1, which makes the blood more prone to clotting. The liver, receiving this constant inflammatory and lipogenic — fat-promoting — signal, responds by becoming insulin resistant, producing more VLDL particles (a harmful type of fat-carrying particle in the blood), and accumulating fat itself in what we call metabolic-associated steatotic liver disease, previously known as fatty liver disease.

This is where the four pillars of cardiometabolic risk — elevated blood pressure, elevated ApoB and LDL particle burden (the most accurate measures of harmful cholesterol-carrying particles), disrupted insulin and glucose metabolism, and visceral fat itself — become not four separate problems but one interconnected system, with VAT driving dysfunction across all the others simultaneously. Hyperinsulinaemic clamp studies, which are the gold-standard method for measuring how well the body responds to insulin, consistently show a direct inverse relationship between visceral fat volume and insulin sensitivity. The more visceral fat, the more insulin resistant the body becomes — and this relationship holds even after adjusting for total body fat.

This is why visceral fat is not merely associated with cardiometabolic disease. It is driving it.

What You Can Do — Practical Steps to Measure and Reduce Your VAT

The first step is measurement, because you cannot manage what you cannot see. Take a tape measure and measure your waist at the level of your navel, first thing in the morning before eating. Divide that number by your height — both in the same units. If the result is 0.5 or above, your visceral fat burden is likely elevated and worth discussing with your doctor or practice nurse. In the UK, you can raise this at an NHS Health Check appointment, which is offered to adults aged 40 to 74. In the USA, this conversation belongs at your annual wellness visit or with a primary care physician who screens for metabolic syndrome.

Exercise is one of the most powerful tools available — and the evidence here is genuinely encouraging. Studies consistently show that aerobic exercise, and particularly a combination of aerobic and resistance training, reduces visceral fat significantly even when total body weight barely changes. The mechanism is partly hormonal and partly mechanical — muscle tissue actively competes with fat for fuel, and trained muscle is far more effective at clearing glucose from the blood, reducing the insulin signal that drives VAT accumulation. You do not need to lose a stone to make a meaningful dent in your visceral fat. Three to five sessions of moderate-intensity exercise per week — brisk walking, cycling, swimming, strength training — can shift visceral fat measurably within eight to twelve weeks.

Diet quality matters enormously here. Ultra-processed foods, refined carbohydrates and excess fructose are particularly potent drivers of visceral fat accumulation and hepatic fat. Shifting towards whole foods, adequate protein — around 1.2 to 1.6 grams per kilogram of body weight daily is a sensible target — and reducing liquid calories is not a diet, it is a physiological

Summary

Two people can share the same weight and BMI yet have completely different risks of heart attack and type 2 diabetes. The difference is often visceral fat — the hidden fat wrapped around your organs. This article explains what it does, why scales miss it, and how to reduce it.

VAT Trap

Visceral Adipose Tissue (VAT) as a Major Modifiable Driver of Cardiometabolic Risk

The Patient Nobody Expected to Be at Risk

What Visceral Fat Is Actually Doing Inside You

What You Can Do — Practical Steps to Measure and Reduce Your VAT

Summary

Related Blog Articles

Recent Posts